Medicare Enrolled

Dr. Jon Miyakawa, M.D.

Family Medicine · Tulare, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
901 N BLACKSTONE AVE, Tulare, CA 93274
5596881992
In practice since 2006 (19 years)
NPI: 1154425536 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Miyakawa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Miyakawa? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Miyakawa

Dr. Jon Miyakawa is a family medicine specialist in Tulare, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Miyakawa performed 2,198 Medicare services across 1,220 unique beneficiaries.

Between the years covered by Open Payments, Dr. Miyakawa received a total of $54,360 from 63 pharmaceutical and/or device companies across 945 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Miyakawa is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 9% volume in CA $54,360 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,198
Medicare services
Top 9% in CA for family medicine
1,220
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~116 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,139 $82 $204
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
464 $58 $138
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
310 $131 $222
Initial nursing facility care, high complexity
An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes.
114 $141 $312
Nursing facility visit, established patient, straightforward
A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes.
57 $31 $84
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
37 $11 $32
Ear wax removal
A procedure to remove impacted ear wax from the ear canal.
21 $35 $94
Manual urinalysis with microscopic examination
A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities.
16 $4 $20
Nursing facility visit, low complexity
A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care.
15 $28 $129
Initial preventive physical examination, new Medicare beneficiary
A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care.
13 $168 $316
Home health plan of care certification
Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians.
12 $36 $94
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$54,360
Total received (2018-2024)
Avg $7,766/year across 7 years
Top 1% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
945
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$37,418 (68.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,941 (31.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,406
2023
$1,990
2022
$1,572
2021
$9,127
2020
$8,763
2019
$14,133
2018
$16,369

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$516
Lilly USA, LLC
$455
ABBVIE INC.
$337
Novo Nordisk Inc
$334
Amgen Inc.
$151
Otsuka America Pharmaceutical, Inc.
$141
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$133
Astellas Pharma US Inc
$80
Boehringer Ingelheim Pharmaceuticals, Inc.
$66
Exact Sciences Corporation
$28
Takeda Pharmaceuticals U.S.A., Inc.
$27
Neurocrine Biosciences, Inc.
$25
Edwards Lifesciences Corporation
$23
Abbott Laboratories
$20
PFIZER INC.
$18
Novartis Pharmaceuticals Corporation
$18
Esperion Therapeutics, Inc.
$17
Dexcom, Inc.
$17
Top 3 companies account for 54.3% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$37,621
AstraZeneca Pharmaceuticals LP
$2,934
Novo Nordisk Inc
$2,460
Lilly USA, LLC
$1,102
Takeda Pharmaceuticals U.S.A., Inc.
$893
Boehringer Ingelheim Pharmaceuticals, Inc.
$884
PFIZER INC.
$826
ABBVIE INC.
$794
AbbVie Inc.
$537
Amarin Pharma Inc.
$504
Merck Sharp & Dohme Corporation
$488
GlaxoSmithKline, LLC.
$462
Janssen Pharmaceuticals, Inc
$461
Allergan, Inc.
$387
SANOFI-AVENTIS U.S. LLC
$347
Astellas Pharma US Inc
$284
Novartis Pharmaceuticals Corporation
$255
Biohaven Pharmaceuticals, Inc.
$232
Biohaven Pharmaceutical Holding Company Ltd.
$197
Bayer HealthCare Pharmaceuticals Inc.
$176
Synergy Pharmaceuticals Inc
$174
Otsuka America Pharmaceutical, Inc.
$153
Edwards Lifesciences Corporation
$142
MannKind Corporation
$137
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$133
AbbVie, Inc.
$129
Abbott Laboratories
$127
BioDelivery Sciences International, Inc.
$125
Adamas Pharmaceuticals, Inc.
$116
E.R. Squibb & Sons, L.L.C.
$100
Avanir Pharmaceuticals, Inc.
$88
Dexcom, Inc.
$80
Sumitomo Pharma America, Inc.
$79
SUN PHARMACEUTICAL INDUSTRIES INC.
$72
Mannkind Corporation
$66
Eisai Inc.
$64
Allergan Inc.
$51
Esperion Therapeutics, Inc.
$49
Radius Health, Inc.
$46
Teva Pharmaceuticals USA, Inc.
$44
ARBOR PHARMACEUTICALS, INC.
$43
Regeneron Healthcare Solutions, Inc.
$40
Merck Sharp & Dohme LLC
$36
UPSHER-SMITH LABORATORIES LLC
$34
Bayer Healthcare Pharmaceuticals Inc.
$33
Sunovion Pharmaceuticals Inc.
$32
Exact Sciences Corporation
$28
Avadel Specialty Pharmaceuticals, LLC
$28
Medtronic MiniMed, Inc.
$28
Neurocrine Biosciences, Inc.
$25
IDORSIA PHARMACEUTICALS US INC
$22
UCB, Inc.
$22
Kowa Pharmaceuticals America, Inc.
$22
Intercept Pharmaceuticals, Inc.
$20
ACADIA Pharmaceuticals Inc
$17
Corcept Therapeutics
$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Circassia Pharmaceuticals Inc
$15
Mylan Specialty L.P.
$15
UROVANT SCIENCES INC
$13
Philips Electronics North America Corporation
$13
DERMIRA, INC.
$12
Horizon Therapeutics plc
$12
Top 3 companies account for 79.1% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · AFREZZA · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · Androgel · BAQSIMI · BELBUCA · BELSOMRA · BREZTRI · BYDUREON · Briviact · CAPLYTA · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · CREON · Cologuard Collection Kit · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · EVKEEZA · Edarbi · Edarbyclor · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GEMTESA · GOCOVRI · INGREZZA · INVOKANA · JANUVIA · JARDIANCE · KAPSPARGO · KRYSTEXXA · Kerendia · Korlym · LEQVIO · LINZESS · LONHALA MAGNAIR · LYRICA · Livalo · MOUNJARO · MOVANTIK · MYRBETRIQ · Myrbetriq · NEXLETOL · NUEDEXTA · NUPLAZID · NURTEC ODT · Noctiva · NovoLog · OCALIVA · Otezla · Ozempic · PAXLOVID · PRALUENT ALIROCUMAB INJECTION · PREMARIN · PREVNAR - 13 · PREVNAR 13 · Prolia · QBREXZA · QULIPTA · QUVIVIQ · REBINYN · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Synthroid · TEZSPIRE · TOSYMRA · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TUDORZA PRESSAIR · Tresiba · Trintellix · Trulance · Tymlos · UBRELVY · VESICARE · VIBERZI · VRAYLAR · Vascepa · Victoza · XARELTO · XIFAXAN · Yupelri · iPro2
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (69%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in family medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for family medicine in CA.

Looking for a family medicine specialist in Tulare?
Compare family medicine physicians in the Tulare area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
153
Per 100K population
32.2
County median income
$69,489
Nearest hospital
ADVENTIST HEALTH TULARE
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Miyakawa is a clinical cardiology specialist, with above-average Medicare volume (top 9% in CA), with speaking/promotional industry engagement in the top 1% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Miyakawa experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Miyakawa performed 1,139 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Miyakawa receive payments from pharmaceutical companies?
Yes. Dr. Miyakawa received a total of $54,360 from 63 companies across 945 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Miyakawa's costs compare to other family medicine physicians in Tulare?
Dr. Miyakawa's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Miyakawa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →